Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

BrightSpring Health Services (BTSG) Competitors

BrightSpring Health Services logo
$56.72 +0.54 (+0.96%)
Closing price 04:00 PM Eastern
Extended Trading
$56.75 +0.03 (+0.05%)
As of 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BTSG vs. NTRA, GH, FMS, PACS, and CELC

Should you buy BrightSpring Health Services stock or one of its competitors? MarketBeat compares BrightSpring Health Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BrightSpring Health Services include Natera (NTRA), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does BrightSpring Health Services compare to Natera?

Natera (NASDAQ:NTRA) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Natera presently has a consensus price target of $256.60, indicating a potential upside of 30.89%. BrightSpring Health Services has a consensus price target of $56.29, indicating a potential downside of 0.77%. Given Natera's higher possible upside, analysts plainly believe Natera is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
1 Sell rating(s)
3 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.79
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$2.31B12.17-$208.16M-$1.63N/A
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-9.05% -14.74% -10.27%
BrightSpring Health Services 2.27%14.63%4.41%

Natera has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market.

99.9% of Natera shares are owned by institutional investors. 5.6% of Natera shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Natera and Natera both had 6 articles in the media. Natera's average media sentiment score of 0.98 beat BrightSpring Health Services' score of 0.45 indicating that Natera is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

BrightSpring Health Services beats Natera on 11 of the 16 factors compared between the two stocks.

How does BrightSpring Health Services compare to Guardant Health?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23
Guardant Health$982.02M13.26-$416.28M-$3.39N/A

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Guardant Health -40.10%N/A -26.42%

In the previous week, Guardant Health had 7 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Guardant Health and 6 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 0.53 beat BrightSpring Health Services' score of 0.45 indicating that Guardant Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
5 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

92.6% of Guardant Health shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market.

BrightSpring Health Services currently has a consensus target price of $56.29, indicating a potential downside of 0.77%. Guardant Health has a consensus target price of $129.42, indicating a potential upside of 31.81%. Given Guardant Health's higher probable upside, analysts plainly believe Guardant Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12
Guardant Health
1 Sell rating(s)
1 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

BrightSpring Health Services beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
BrightSpring Health Services 2.27%14.63%4.41%

In the previous week, BrightSpring Health Services had 6 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for BrightSpring Health Services and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat BrightSpring Health Services' score of 0.45 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Overall Sentiment
Fresenius Medical Care AG & Co. KGaA Very Positive
BrightSpring Health Services Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.56$1.11B$1.9011.64
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, suggesting a potential upside of 26.56%. BrightSpring Health Services has a consensus price target of $56.29, suggesting a potential downside of 0.77%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to PACS Group?

BrightSpring Health Services (NASDAQ:BTSG) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

PACS Group has lower revenue, but higher earnings than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23
PACS Group$5.29B1.10$191.54M$1.5623.60

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
PACS Group 4.49%26.47%4.36%

BrightSpring Health Services has a beta of 1.71, indicating that its stock price is 71% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.03, indicating that its stock price is 103% less volatile than the broader market.

In the previous week, PACS Group had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 8 mentions for PACS Group and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.45 beat PACS Group's score of 0.39 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrightSpring Health Services currently has a consensus price target of $56.29, suggesting a potential downside of 0.77%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 30.36%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

BrightSpring Health Services beats PACS Group on 8 of the 15 factors compared between the two stocks.

How does BrightSpring Health Services compare to Celcuity?

BrightSpring Health Services (NASDAQ:BTSG) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Celcuity N/A -244.61%-50.22%

In the previous week, Celcuity had 10 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Celcuity and 6 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.45 beat Celcuity's score of 0.35 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Celcuity
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.85$190.67M$1.4140.23
CelcuityN/AN/A-$177.04M-$3.90N/A

63.3% of Celcuity shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 13.3% of Celcuity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

BrightSpring Health Services has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market.

BrightSpring Health Services currently has a consensus target price of $56.29, indicating a potential downside of 0.77%. Celcuity has a consensus target price of $149.30, indicating a potential upside of 13.89%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$10.89B$8.13B$6.25B$12.23B
Dividend YieldN/A3.12%2.80%5.27%
P/E Ratio40.2320.5520.7925.04
Price / Sales0.8516.32531.2172.18
Price / Cash25.5780.7843.0954.25
Price / Book5.565.499.816.83
Net Income$190.67M$180.93M$3.55B$335.69M
7 Day Performance2.20%-1.54%-2.07%-2.03%
1 Month Performance19.99%-0.97%-3.90%-1.90%
1 Year Performance135.26%-0.18%29.39%27.36%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
2.9292 of 5 stars
$56.72
+1.0%
$56.29
-0.8%
+130.0%$10.89B$12.91B40.2323,500
NTRA
Natera
3.9014 of 5 stars
$201.18
+1.0%
$256.60
+27.6%
+26.2%$28.67B$2.31BN/A6,140
GH
Guardant Health
3.3455 of 5 stars
$95.35
-1.4%
$129.42
+35.7%
+135.2%$12.63B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.8456 of 5 stars
$22.19
+2.0%
$28.00
+26.2%
-22.7%$12.39B$22.20B11.671,488
PACS
PACS Group
3.8545 of 5 stars
$40.34
+26.5%
$44.40
+10.1%
+242.3%$6.30B$5.29B32.6147,455

Related Companies and Tools


This page (NASDAQ:BTSG) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners